Corvus Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 02/17/2026 | 7.17 M | $55.17 M | 0.00% | 8.65% |
| BLACKROCK, INC. | 02/12/2026 | 5.06 M | $38.93 M | 7.34% | 6.10% |
| VANGUARD GROUP INC | 01/29/2026 | 3.87 M | $29.83 M | 11.57% | 4.68% |
| MORGAN STANLEY | 02/13/2026 | 3.57 M | $27.47 M | 478.06% | 4.31% |
| ADAMS STREET PARTNERS LLC | 02/13/2026 | 3.28 M | $25.22 M | 0.00% | 3.95% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 2.88 M | $22.14 M | -55.46% | 3.47% |
| STATE STREET CORP | 02/13/2026 | 2.79 M | $21.47 M | 177.07% | 3.37% |
| BIOIMPACT CAPITAL LLC | 02/17/2026 | 2.74 M | $21.13 M | 100.00% | 3.31% |
| VIVO CAPITAL, LLC | 02/13/2026 | 2.23 M | $17.21 M | 0.00% | 2.70% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.47 M | $11.35 M | 1.13% | 1.78% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 02/17/2026 | 1.38 M | $10.64 M | -20.22% | 1.67% |
| DCF ADVISERS, LLC | 02/11/2026 | 729.00 K | $5.61 M | 100.00% | 0.88% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 692.44 K | $5.33 M | -51.87% | 0.84% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 688.77 K | $5.30 M | 100.00% | 0.83% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 553.33 K | $4.26 M | 24.16% | 0.67% |
| LOGOS GLOBAL MANAGEMENT LP | 02/17/2026 | 500.00 K | $3.85 M | 100.00% | 0.60% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 465.88 K | $3.59 M | 100.00% | 0.56% |
| RTW INVESTMENTS, LP | 02/17/2026 | 447.61 K | $3.45 M | -83.30% | 0.54% |
| NORTHERN TRUST CORP | 02/17/2026 | 429.77 K | $3.31 M | -7.87% | 0.52% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/17/2026 | 407.71 K | $3.14 M | 0.00% | 0.49% |
| BARCLAYS PLC | 02/13/2026 | 394.77 K | $3.04 M | 27.69% | 0.48% |
| JANE STREET GROUP, LLC | 02/12/2026 | 378.30 K | $2.91 M | 455.78% | 0.46% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 344.10 K | $2.65 M | 129.55% | 0.42% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 314.68 K | $2.42 M | 74.65% | 0.38% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 260.20 K | $2.00 M | 490.02% | 0.31% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 236.50 K | $1.82 M | 55.62% | 0.29% |
| MARSHALL WACE, LLP | 02/13/2026 | 216.25 K | $1.67 M | 100.00% | 0.26% |
| UBS GROUP AG | 01/29/2026 | 212.01 K | $1.63 M | 30.81% | 0.26% |
| CITADEL ADVISORS LLC | 02/17/2026 | 208.18 K | $1.60 M | 386.79% | 0.25% |
| CITADEL ADVISORS LLC | 02/17/2026 | 175.00 K | $1.35 M | 161.98% | 0.21% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 171.17 K | $1.32 M | -3.72% | 0.21% |
| EMPIRICAL FINANCIAL SERVICES, LLC D.B.A. EMPIRICAL WEALTH MANAGEMENT | 01/16/2026 | 167.40 K | $1.29 M | -1.06% | 0.20% |
| FRED ALGER MANAGEMENT, LLC | 02/17/2026 | 144.38 K | $1.11 M | 100.00% | 0.17% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 143.60 K | $1.11 M | -29.39% | 0.17% |
| TOWERVIEW LLC | 02/04/2026 | 140.00 K | $1.08 M | -17.65% | 0.17% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 131.63 K | $1.01 M | 4.03% | 0.16% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 121.16 K | $932.91 K | -2.68% | 0.15% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 114.50 K | $881.65 K | 100.00% | 0.14% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 105.90 K | $815.43 K | 100.00% | 0.13% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 104.82 K | $807.11 K | 100.00% | 0.13% |
| RAFFERTY ASSET MANAGEMENT, LLC | 02/13/2026 | 99.72 K | $767.88 K | 100.00% | 0.12% |
| CITADEL ADVISORS LLC | 02/17/2026 | 93.80 K | $722.26 K | 94.61% | 0.11% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/17/2026 | 86.72 K | $667.74 K | 100.00% | 0.10% |
| NEOS INVESTMENT MANAGEMENT LLC | 02/17/2026 | 80.89 K | $622.88 K | 36.64% | 0.10% |
| TEMA ETFS LLC | 01/16/2026 | 79.70 K | $613.68 K | 34.62% | 0.10% |
| RHUMBLINE ADVISERS | 02/13/2026 | 70.73 K | $544.59 K | -14.36% | 0.09% |
| NUVEEN, LLC | 02/12/2026 | 68.06 K | $524.09 K | 0.00% | 0.08% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 67.99 K | $523.55 K | 0.00% | 0.08% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 64.92 K | $499.85 K | 153.82% | 0.08% |
| JACKSON SQUARE CAPITAL, LLC | 01/21/2026 | 63.77 K | $491.05 K | 0.00% | 0.08% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Corvus Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 180 institutional investors and hedge funds held shares of Corvus Pharmaceuticals Inc. The most heavily invested institutionals were:
EMERALD ADVISERS, LLC: 686,216
DCF Advisers, LLC: 637,500
VANGUARD FIDUCIARY TRUST CO: 504,631
EMERALD MUTUAL FUND ADVISERS TRUST: 459,253
UBS Group AG: 289,114
Bank of New York Mellon Corp: 185,347
56.36% of Corvus Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 52.06 M shares in the last 24 months. This purchase volume represents approximately $827.21 M in transactions.